Seize the Opportunity to Implement the Strategy of a Powerful Country in Bioeconomy My annual output value of the biological industry will increase by 30%. The value added in 2010 will reach 500 billion yuan.

On October 21st, it was learned from the National Development and Reform Commission that China’s modern biotechnology has grown by leaps and bounds in recent years, and its industrial output value has grown by an average of 30% annually. Experts suggest that we should firmly grasp the major strategic opportunities of the biotech revolution and the industrial revolution. The stools are the first to be hosted by the National Development and Reform Commission and the Ministry of Science and Technology. The figures of the above figures were known during the statistics of the results of the 7th China International Hi-tech Fair. This year's Hi-tech Fair will focus on the major achievements made by our country in recent years in the industrialization of human embryonic stem cells, fuel ethanol and other biotechnologies.
According to reports, since 1996, the National Development and Reform Commission has organized and implemented biotechnology industrialization projects for six consecutive years, focusing on the implementation of major special projects such as biomedicine, new chemical synthesis drugs, biomedical engineering, energy substitution, and modern agriculture. The state allocated 2.87 billion yuan of funds to attract 32.8 billion yuan of social investment, supported 387 biotechnology industrialization projects, and accounted for 23.4% of all industrialization projects. According to statistics, last year China’s bio-industry realized a production value of RMB 420 billion, an increase of RMB 120 billion. Among them, the modern bio-industry realized a production value of 47 billion yuan and an added value of 12 billion yuan. From 2000 to 2004, the output value of modern biological industries increased by 30% annually. By 2010, the added value of the biological industry will reach 500 billion yuan, accounting for 3% of GDP. On this basis, through 10 years of efforts, the major economic indicators of the Chinese bio-industry rank among the top three in the world. The main bio-tech products can meet the basic needs of the people. By 2020, the national added value of the biological industry is expected to exceed 2 trillion yuan, accounting for more than 5% of GDP.
Biotechnology is the most active factor in productivity after information technology. It is widely believed that it will promote economic development and social progress as much as information technology. In the "China's Bio-industry Development Strategy Study" led and organized by the National Development and Reform Commission at the beginning of this year, experts suggested that China should seize the opportunity to implement the strategy of strengthening the country's bio-economy, and strive to develop China's bio-industry through 10 to 15 years of efforts. It has become an emerging leading industry with breakthrough and major driving actions.

NINGBO RUICAN MACHINERY COMPANY can meet high and tight tolerance by CNC MACHINING process with [igs" or "stp" format drawings.


Our Machining Capabilities:

CNC Turning – CNC multi-axis machining centers for superior speed & flexibility
Custom Machining - expert machined components delivered on time
Screw Machine Products – precision components from a broad variety of materials & Equipment
Machining – micro-parts to 1-1/2 round diameter providing speed, high capability including precision tolerances and specialized finishes
High Volume Machining – Specialized in machined parts exceeding 500 pieces up to millions of pieces for optimum efficiency
CNC Milling - Machining from bar stock, plate or block metal using up to 3 axis of motion

Steel material machining parts

Steel Material Machining Parts,Custom Metal Parts Fabrication,Steel Material CNC Machining Parts,Machining Stainless Steel Parts

Ningbo City Yinzhou Ruican Machinery Co.,Ltd , https://www.kstcasting.com